27 Nov 2020

Haoma Medica concludes trial of oral osteoporosis treatment

Clinical-stage biotech firm Haoma Medica has completed a first-in-human trial for novel orally administered therapeutic, NaQuinate, being developed for osteoporosis. Osteoporosis is often present without any signs or symptoms until…

26 Nov 2020

Celltrion concludes enrolment in global Covid-19 antibody trial

Celltrion Group has completed enrolment of 327 patients with mild-to-moderate SARS-CoV-2 infection symptoms to evaluate anti-Covid-19 monoclonal antibody treatment candidate CT-P59 in the global Phase II clinical trial. CT-P59 was…